Am J Perinatol 2018; 35(11): 1093-1099
DOI: 10.1055/s-0038-1641168
DOI: 10.1055/s-0038-1641168
Original Article
Are Anti-β2 Glycoprotein 1 Antibodies Associated with Placenta-Mediated Pregnancy Complications? A Nested Case–Control Study
Autor*innen
-
Leslie Skeith
1 Division of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Calgary, Alberta, Canada2 Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada -
Karim E. Abou-Nassar
3 Service d'Hématologie et Axe de Recherche en Cancérologie, Centre Intégré de Santé et de Services Sociaux de l'Outaouais, Gatineau, Quebec, Canada -
Mark Walker
2 Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada4 Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, Ontario, Canada -
Tim Ramsay
2 Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada -
Ronald Booth
2 Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada -
Shi Wu Wen
2 Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada4 Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, Ontario, Canada -
Graeme N. Smith
5 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Queen's University, Kingston, Ontario, Canada -
Marc A. Rodger
2 Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada4 Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, Ontario, Canada6 Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada

